Tempus AI (NASDAQ:TEM) Trading Up 5.3% – Should You Buy?

Tempus AI, Inc. (NASDAQ:TEM) rose 5.3% on Monday . The stock traded as high as $59.80 and last traded at $60.40. Approximately 6,700,130 shares changed hands during trading, a decline of 34% from the average daily volume of 10,095,790 shares. The stock had previously closed at $57.39.

Wall Street Analyst Weigh In

TEM has been the topic of a number of research analyst reports. Loop Capital lowered their target price on Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a report on Tuesday, January 14th. Bank of America raised their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Wolfe Research initiated coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 target price for the company. Stifel Nicolaus lowered shares of Tempus AI from a “buy” rating to a “hold” rating and raised their price target for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $56.00 price objective on shares of Tempus AI in a research report on Tuesday, January 14th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $56.36.

Tempus AI Stock Up 7.3 %

The company has a 50-day moving average of $44.18 and a 200 day moving average of $48.29. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, COO Ryan Fukushima sold 120,000 shares of Tempus AI stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.51, for a total value of $5,101,200.00. Following the completion of the transaction, the chief operating officer now owns 1,007,207 shares in the company, valued at approximately $42,816,369.57. The trade was a 10.65 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Ryan M. Bartolucci sold 13,770 shares of the business’s stock in a transaction on Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the completion of the transaction, the chief accounting officer now directly owns 57,237 shares in the company, valued at approximately $3,434,220. This represents a 19.39 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 2,037,702 shares of company stock valued at $89,449,651.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. acquired a new stake in Tempus AI in the 3rd quarter valued at about $30,000. FNY Investment Advisers LLC bought a new stake in shares of Tempus AI during the fourth quarter valued at approximately $67,000. Vestor Capital LLC acquired a new stake in shares of Tempus AI in the third quarter valued at approximately $153,000. Mirae Asset Global Investments Co. Ltd. bought a new position in Tempus AI in the 4th quarter worth approximately $178,000. Finally, Stifel Financial Corp bought a new stake in shares of Tempus AI during the third quarter worth $218,000. 24.22% of the stock is owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.